SpacDeskCIK0001764013 — Shareholder Vote
Health Sciences Acquisitions Corporation · 2022-08-17
Approval, on a Non-Binding Advisory Basis, of the Compensation of Immunovant’s Named Executive Officers
Vote type
other
Outcome
passed
Shares for
87,519,754
Shares against
14,824,750
Data sourced from SEC EDGAR filings. Dates reflect the vote/event date as disclosed in the filing. Outcomes updated when follow-up filings are published.